drugset / Trial / NCT00366262
Study Evaluating the Gastrointestinal Safety of PLA-695 Compared to Placebo and Naproxen
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to provide an initial assessment of the gastrointestinal safety of a 7-day regimen of PLA-695 compared to placebo or naproxen.
Timeline
- Start
- 2006-06
- Primary completion
- —
- Completion
- 2007-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GIRIPLADIB | Small molecule | — | — |
| Subject | Naproxen | Small molecule | — | — |
Indications
No indication recorded.